235 related articles for article (PubMed ID: 30702437)
1. Use of the CHA2DS2-VASc Score for Risk Stratification of Hospital Admissions Among Patients With Cardiovascular Diseases Receiving a Fourth-Generation Synchronous Telehealth Program: Retrospective Cohort Study.
Lee JK; Hung CS; Huang CC; Chen YH; Chuang PY; Yu JY; Ho YL
J Med Internet Res; 2019 Jan; 21(1):e12790. PubMed ID: 30702437
[TBL] [Abstract][Full Text] [Related]
2. The Costs and Cardiovascular Benefits in Patients With Peripheral Artery Disease From a Fourth-Generation Synchronous Telehealth Program: Retrospective Cohort Study.
Lee JK; Hung CS; Huang CC; Chen YH; Wu HW; Chuang PY; Yu JY; Ho YL
J Med Internet Res; 2021 May; 23(5):e24346. PubMed ID: 34003132
[TBL] [Abstract][Full Text] [Related]
3. CHA
Kim TH; Yang PS; Uhm JS; Kim JY; Pak HN; Lee MH; Joung B; Lip GYH
Stroke; 2017 Jun; 48(6):1524-1530. PubMed ID: 28455320
[TBL] [Abstract][Full Text] [Related]
4. Assessment of the CHA2DS2-VASc Score in Predicting Ischemic Stroke, Thromboembolism, and Death in Patients With Heart Failure With and Without Atrial Fibrillation.
Melgaard L; Gorst-Rasmussen A; Lane DA; Rasmussen LH; Larsen TB; Lip GY
JAMA; 2015 Sep; 314(10):1030-8. PubMed ID: 26318604
[TBL] [Abstract][Full Text] [Related]
5. The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation.
Roldán V; Marín F; Manzano-Fernández S; Gallego P; Vílchez JA; Valdés M; Vicente V; Lip GY
J Am Coll Cardiol; 2013 Dec; 62(23):2199-204. PubMed ID: 24055744
[TBL] [Abstract][Full Text] [Related]
6. Assessment of the cost-effectiveness and clinical outcomes of a fourth-generation synchronous telehealth program for the management of chronic cardiovascular disease.
Ho YL; Yu JY; Lin YH; Chen YH; Huang CC; Hsu TP; Chuang PY; Hung CS; Chen MF
J Med Internet Res; 2014 Jun; 16(6):e145. PubMed ID: 24915187
[TBL] [Abstract][Full Text] [Related]
7. CHA
Parsons C; Patel SI; Cha S; Shen WK; Desai S; Chamberlain AM; Luis SA; Aguilar MI; Demaerschalk BM; Mookadam F; Shamoun F
Mayo Clin Proc; 2017 Mar; 92(3):360-369. PubMed ID: 28259228
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of CHA2DS2-VASc score in predicting high SYNTAX score and in-hospital mortality for non-ST elevation myocardial infarction in patients without atrial fibrillation.
Akboğa MK; Yılmaz S; Yalçın R
Anatol J Cardiol; 2021 Nov; 25(11):789-795. PubMed ID: 34734812
[TBL] [Abstract][Full Text] [Related]
9. CHA
Peacock WF; Tamayo S; Patel M; Sicignano N; Hopf KP; Yuan Z
Ann Emerg Med; 2017 May; 69(5):541-550.e1. PubMed ID: 27913059
[TBL] [Abstract][Full Text] [Related]
10. Mortality Benefit of a Fourth-Generation Synchronous Telehealth Program for the Management of Chronic Cardiovascular Disease: A Longitudinal Study.
Hung CS; Yu JY; Lin YH; Chen YH; Huang CC; Lee JK; Chuang PY; Ho YL; Chen MF
J Med Internet Res; 2016 May; 18(5):e102. PubMed ID: 27177497
[TBL] [Abstract][Full Text] [Related]
11. CHA2DS2-VASc score is directly associated with the risk of pulmonary embolism in patients with atrial fibrillation.
Saliba W; Rennert G
Am J Med; 2014 Jan; 127(1):45-52. PubMed ID: 24384101
[TBL] [Abstract][Full Text] [Related]
12. Validation of a Modified CHA2DS2-VASc Score for Stroke Risk Stratification in Asian Patients With Atrial Fibrillation: A Nationwide Cohort Study.
Chao TF; Lip GY; Liu CJ; Tuan TC; Chen SJ; Wang KL; Lin YJ; Chang SL; Lo LW; Hu YF; Chen TJ; Chiang CE; Chen SA
Stroke; 2016 Oct; 47(10):2462-9. PubMed ID: 27625386
[TBL] [Abstract][Full Text] [Related]
13. The CHADS2 and CHA2DS2-VASc scores predict adverse vascular function, ischemic stroke and cardiovascular death in high-risk patients without atrial fibrillation: role of incorporating PR prolongation.
Chan YH; Yiu KH; Lau KK; Yiu YF; Li SW; Lam TH; Lau CP; Siu CW; Tse HF
Atherosclerosis; 2014 Dec; 237(2):504-13. PubMed ID: 25463082
[TBL] [Abstract][Full Text] [Related]
14. Costs and Cardiovascular Benefits of a Fourth-Generation Synchronous Telehealth Program on Mortality and Cardiovascular Outcomes for Patients With Atrial Fibrillation: Retrospective Cohort Study.
Chang HY; Wu HW; Hung CS; Chen YH; Huang CC; Yang LT; Hwang ST; Yu JY; Lee JK; Ho YL
J Med Internet Res; 2024 Jan; 26():e48748. PubMed ID: 38190237
[TBL] [Abstract][Full Text] [Related]
15. CHA
Kim TH; Yang PS; Kim D; Yu HT; Uhm JS; Kim JY; Pak HN; Lee MH; Joung B; Lip GYH
Stroke; 2017 Nov; 48(11):2984-2990. PubMed ID: 28939672
[TBL] [Abstract][Full Text] [Related]
16. Should atrial fibrillation patients with 1 additional risk factor of the CHA2DS2-VASc score (beyond sex) receive oral anticoagulation?
Chao TF; Liu CJ; Wang KL; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Chen TJ; Lip GY; Chen SA
J Am Coll Cardiol; 2015 Feb; 65(7):635-42. PubMed ID: 25677422
[TBL] [Abstract][Full Text] [Related]
17. CHA2DS2-VASc and ATRIA Scores and Clinical Outcomes in Patients with Heart Failure with Preserved Ejection Fraction.
Zhu W; Wu Y; Zhou Y; Liang W; Xue R; Wu Z; Dong Y; Liu C
Cardiovasc Drugs Ther; 2020 Dec; 34(6):763-772. PubMed ID: 32583288
[TBL] [Abstract][Full Text] [Related]
18. CHA
Gigante A; Imbimbo G; Andreini M; Proietti M; Palladino M; Molfino A; Alunni Fegatelli D; Muscaritoli M
J Nephrol; 2024 Mar; 37(2):409-417. PubMed ID: 37938543
[TBL] [Abstract][Full Text] [Related]
19. The impact of risk score (CHADS2 versus CHA2DS2-VASc) on long-term outcomes after atrial fibrillation ablation.
Jacobs V; May HT; Bair TL; Crandall BG; Cutler M; Day JD; Weiss JP; Osborn JS; Muhlestein JB; Anderson JL; Mallender C; Bunch TJ
Heart Rhythm; 2015 Apr; 12(4):681-6. PubMed ID: 25546809
[TBL] [Abstract][Full Text] [Related]
20. CHA₂DS₂-VASc scores predict mortality after hospitalization for atrial fibrillation.
Apiyasawat S; Tangcharoen T; Wisaratapong T; Yamwong S; Wiboonpolprasert S; Sritara P
Int J Cardiol; 2015 Apr; 185():293-6. PubMed ID: 25819735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
